Derivatives of PPD useful for coloring hair and skin

US11129782B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11129782-B2
Application numberUS-202016875189-A
CountryUS
Kind codeB2
Filing dateMay 15, 2020
Priority dateNov 15, 2017
Publication dateSep 28, 2021
Grant dateSep 28, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The is provided a compound of formula I or II or physiologically acceptable salts or solvates, or oxidised derivatives thereof: where R 1 to R 3 , R 13 and R 14 are as defined herein. Also disclosed herein are methods of dyeing hair or (temporarily) tattooing the skin using the compounds of formula I or II (or physiologically acceptable salts or solvates, or oxidised derivatives thereof) in a suitable composition.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula I: wherein: R 1 and R 2 independently represent H, CH 2 Phenyl or C 5-10 alkyl, which phenyl group is substituted by NO 2 , OCH 3 , CH 3 or OH, and which C 5-15 alkyl group is unsubstituted or substituted with one or more substituents selected from: C 1-10 alkyl, which group is unsubstituted or substituted by one or more substituents selected from OH, nitro, CN, OR 4a , NR 4b R 4c , aryl and Het 1 ; Cy 1 , which Cy 1 group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-10 alkyl (which C 1-10 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, C 1-4 alkyl and C 1-4 alkoxy), and OR 5a , S(O) q R 5b , S(O) 2 NR 5c R 5d , NR 5e S(O) 2 R 5f , NR 5g R 5h ; Het a , which Het a group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-6 alkyl (which C 1-6 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, halo, C 1-4 alkyl and C 1-4 alkoxy), OR 6a , S(O) q R 6b , S(O) 2 NR 6c R 6d , NR 6e S(O) 2 R 6f , NR 6g R 6h ; and OR 7a , S(O) q R 7b , S(O) 2 NR 7c R 7d , NR 7e S(O) 2 R 7f and NR 7g R 7h , R 3 represents H, OC 1-10 alkyl, C(O)OC 1-10 alkyl or OC(O)C 1-10 alkyl, which OC 1-10 alkyl, C(O)OC 1-10 alkyl and OC(O)C 1-10 alkyl groups are unsubstituted or substituted with one or more substituents selected from: C 1-10 alkyl, which group is unsubstituted or substituted by one or more substituents selected from OH, nitro, CN, OR 8a , NR 8b R 8c , aryl and Het 2 ; Cy 2 , which Cy 2 group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-6 alkyl (which C 1-6 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, C 1-4 alkyl and C 1-4 alkoxy), and OR 9a , S(O) q R 9b , S(O) 2 NR 9c R 9d , NR 9e S(O) 2 R 9f , NR 9g R 9h ; Het b , which Het b group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-6 alkyl (which C 1-6 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, halo, C 1-4 alkyl and C 1-4 alkoxy), OR 10a , S(O) q R 10b , S(O) 2 NR 10c R 10d , NR 10e S(O) 2 R 10f , NR 10g R 10h ; and OR 11a , S(O) q R 11b , S(O) 2 NR 11c R 11d , NR 11e S(O) 2 R 11f and NR 11g R 11h , Het 1 and Het 2 represent, independently at each occurrence, a 4- to 14-membered heterocyclic group containing one or more heteroatoms selected from O, S and N, which heterocyclic groups may comprise one, two or three rings and may be substituted by one or more substituents selected from OR 12a and C 1-10 alkyl, which C 1-10 alkyl group is unsubstituted; Cy 1 and Cy 2 represent, independently at each occurrence, a 3- to 6-membered aromatic, fully saturated or partially unsaturated carbocyclic ring; R 4a to R 4c , R 5a to R 5h , R 6a to R 6h , R 7a to R 7h , R 8a to R 8c , R 9a to R 9h , R 10a to R 10h , R 11a to R 11h , independently represent, at each occurrence, H, or C 1-10 alkyl (which C 1-10 alkyl group is unsubstituted or substituted by one or more substituents selected from C 1-6 alkyl, OR 12b ), or R 5-7c and R 5-7d , R 9-11c and R 9-11d , R 5-7g and R 5-7h , R 9-11g and R 9-11h represent, together with the nitrogen atom to which they are attached, a 3- to 14-membered heterocyclic ring that may be aromatic, fully saturated or partially unsaturated and which may additionally contain one or more heteroatoms selected from O, S and N, which heterocyclic ring is optionally substituted by one or more substituents selected from halo, nitro, CN, and C 1-6 alkyl; Het a and Het b independently represent 4- to 14-membered heterocyclic groups containing one or more heteroatoms selected from O, S and N; R 12a-b independently represents, at each occurrence, H or C 1-4 alkyl, and n represents 0 to 4, or a physiologically acceptable salt or solvate, or an oxidised derivative thereof of the compound of formula I, provided that when R 1 and R 2 are H, and n is 0, 1 or 2, R 3 is not H. 2. A method of dyeing hair or of applying a temporary tattoo, which method comprises applying a composition comprising a compound of formula I or a physiologically acceptable salt or solvate, or an oxidised derivative thereof, to the hair or skin of a subject, wherein the compound of formula I has the structure: wherein: R 1 and R 2 independently represent H, CH 2 Phenyl or C 5-10 alkyl, which phenyl group is substituted by NO 2 , OCH 3 , CH 3 or OH, and which C 5-10 alkyl group is unsubstituted or substituted with one or more substituents selected from: C 1-10 alkyl, which group is unsubstituted or substituted by one or more substituents selected from OH, nitro, CN, OR 4a , NR 4b R 4c , aryl and Het 1 ; Cy 1 , which Cy 1 group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-6 alkyl (which C 1-6 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, C 1-4 alkyl and C 1-4 alkoxy), and OR 5a , S(O) q R 5b , S(O) 2 NR 5c R 5d , NR 5e S(O) 2 R 5f , NR 5g R 5h ; Het a , which Het a group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-6 alkyl (which C 1-6 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, halo, C 1-4 alkyl and C 1-4 alkoxy), OR 6a , S(O) q R 6b , S(O) 2 NR 6c R 6d , NR 6e S(O) 2 R 6f , NR 6g R 6h ; and OR 7a , S(O) q R 7b , S(O) 2 NR 7c R 7d , NR 7e S(O) 2 R 7f and NR 7g R 7h , R 3 represents H, C 1-10 alkyl, OC 1-10 alkyl, C(O)OC 1-10 alkyl or OC(O)C 1-10 alkyl, which C 1-10 alkyl, OC 1-10 alkyl, C(O)OC 1-10 alkyl or OC(O)C 1-10 alkyl groups are unsubstituted or substituted with one or more substituents selected from: C 1-10 alkyl, which group is unsubstituted or substituted by one or more substituents selected from OH, nitro, CN, OR 8a , NR 8b R 8c , aryl and Het 2 ; Cy 2 , which Cy 2 group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-6 alkyl (which C 1-6 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, C 1-4 alkyl and C 1-4 alkoxy), and OR 9a , S(O) q R 9b , S(O) 2 NR 9c R 9d , NR 9e S(O) 2 R 9f , NR 9g R 9h ; Het b , which Het b group is unsubstituted or substituted by one or more substituents selected from nitro, CN, C 1-6 alkyl (which C 1-6 alkyl group is unsubstituted or substituted by one or more substituents selected from OH, ═O, halo, C 1-4 alkyl and C 1-4 alkoxy), OR 10a , S(O) q R 10b , S(O) 2 NR 10c R 10d , NR 10e S(O) 2 R 10f , NR 10g R 10h ; and OR 11a , S(O) q R 11b , S(O) 2 NR 11c R 11d , NR 11e S(O) 2 R 11f and NR 11g R 11h , Het 1 and Het 2 represent, independently at each occurrence, a 4- to 14-membered heterocyclic group containing one or more heteroatoms selected from O, S and N, which heterocyclic groups may comprise one, two or three rings and may be substituted by one or more substituents selected from OR 12a and C 1-10 alkyl, which C 1-10 alkyl group is unsubstituted; Cy 1 and Cy 2 represent, independently at each occurrence, a 3- to 6-membered aromatic, fully saturated or partially unsaturated carbocyclic ring; R 4a to R 4c , R 5a to R 5h , R 6a to R 6h , R 7a to R 7h , R 8a to R 8c , R 9a to R 9h , R 10a to R 10h , R 11a to R 11h , independently represent, at each occurrence, H, or C 1-10 alkyl (which C 1-10 alkyl group

Assignees

Inventors

Classifications

  • Azomethine dyes, the C-atom of the group -C=N- being part of a ring (Image) · CPC title

  • Semi-permanent tattoos, stencils, e.g. "permanent make-up" · CPC title

  • Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus · CPC title

  • Preparations for permanently dyeing the hair · CPC title

  • C09B53/02Primary

    Indamines; Indophenols · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11129782B2 cover?
The is provided a compound of formula I or II or physiologically acceptable salts or solvates, or oxidised derivatives thereof: where R 1 to R 3 , R 13 and R 14 are as defined herein. Also disclosed herein are methods of dyeing hair or (temporarily) tattooing the skin using the compounds of formula I or II (or physiologically acceptable salts or solvates, or oxidis…
Who is the assignee on this patent?
Nat Univ Singapore, Agency Science Tech & Res, Nat Univ Hospital Singapore Pte Ltd
What technology area does this patent fall under?
Primary CPC classification C09B53/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).